Cost Effectiveness Analysis
- 1 September 1995
- journal article
- review article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 37 (3) , 436-444
- https://doi.org/10.1227/00006123-199509000-00011
Abstract
MEDICAL TREATMENTS AND strategies are increasingly being subjected to evaluations of economic efficiency. Although the reasons for this are many, it is becoming ever more important for physicians to have an understanding of the uses and limitations of such evaluations. Cost effectiveness analysis (CEA) is a technique that measures the cost of medical technology per unit of a defined health output, usually life years saved with an adjustment for quality of survival. CEA is a popular method of economic evaluation for policy makers, because it can provide direct comparisons among many medical technologies, resulting in a ranked order of procedures based on economic efficiency. The proper interpretation of a CEA requires an understanding of the component parts of the analysis, their theoretical bases, and their limitations. The components of a CEA include the determination of relevant costs, an appropriate analysis viewpoint, the use of discounting for both costs and benefits, and a sensitivity analysis of the assumptions and probabilities that drive the analysis. Marginal and incremental CEAs are techniques that help to address the cost effectiveness of different amounts of a particular treatment and the differential costs and benefits of competing strategies, respectively. A review is presented of the theoretical basis of CEA and its component parts. Emphasis is placed on generating an understanding of the method rather than providing a step-by-step protocol for the undertaking of such studies.Keywords
This publication has 20 references indexed in Scilit:
- Managing Chronic Atrial Fibrillation: A Markov Decision Analysis Comparing Warfarin, Quinidine, and Low-Dose AmiodaroneAnnals of Internal Medicine, 1994
- Patients' Attitude about Outcomes and the Role of Gamma Knife Radiosurgery in the Treatment of Vestibular SchwannomasNeurosurgery, 1994
- What is cost‐effectiveness analysis?The Medical Journal of Australia, 1990
- A review of cost‐effectiveness analysesThe Medical Journal of Australia, 1990
- Clinical EconomicsJAMA, 1989
- Decision Analysis: A Tool of the Future: An Application to Unruptured Arteriovenous MalformationsNeurosurgery, 1989
- Benefit and Cost Analysis in Geriatric CareNew England Journal of Medicine, 1984
- A convenient approximation of life expectancy (the “DEALE”): II. Use in medical decision-makingThe American Journal of Medicine, 1982
- A convenient approximation of life expectancy (the “DEALE”)The American Journal of Medicine, 1982
- The Distinction Between Cost and ChargesAnnals of Internal Medicine, 1982